Debiotech SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Debiotech SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0155
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Debiotech SA (Debiotech) is a medical device company that develops therapeutic devices and diagnostic products. The company’s products include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It develops products in the areas of implantable and external drug delivery systems using nanotechnologies, micromechanics and microelectromechanical systems. Debiotech identifies new technologies and ideas originating from scientists, universities or inventors and brings them to approval by the product for human use. The company also provides research and development services. It markets its products through medical devices and pharmaceutical companies. Debiotech is headquartered in Lausanne, Switzerland.

Debiotech SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Debiotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Debiotech SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Debiotech SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Debiotech SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Debiotech SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Debiotech SA, Medical Equipment, Deal Details 10
Asset Purchase 10
Debiotech to Acquire Product Rights from iSense 10
Partnerships 11
Debiotech Enters into Co-Development Agreement with ARTORG 11
Debiotech and Fresenius Medical Care Enter into Agreement 12
Debiotech Enters Into An Agreement With Awak Technologies To Develop Miniaturized Home Hemodialysis Machine 13
Debiotech SA – Key Competitors 15
Debiotech SA – Key Employees 16
Debiotech SA – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Debiotech SA, Medical Equipment, Key Facts 2
Debiotech SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Debiotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Debiotech SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Debiotech SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Debiotech SA, Deals By Market, 2012 to YTD 2018 8
Debiotech SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Debiotech to Acquire Product Rights from iSense 10
Debiotech Enters into Co-Development Agreement with ARTORG 11
Debiotech and Fresenius Medical Care Enter into Agreement 12
Debiotech Enters Into An Agreement With Awak Technologies To Develop Miniaturized Home Hemodialysis Machine 13
Debiotech SA, Key Competitors 15
Debiotech SA, Key Employees 16

List of Figures
Debiotech SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Debiotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Debiotech SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Debiotech SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Debiotech SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Debiotech SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Debiotech SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Debiotech SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Debiotech SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Advance Syntex Ltd:企業の戦略的SWOT分析
    Advance Syntex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Lietuvos energijos gamyba, AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba, AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ascena Retail Group, Inc. (ASNA):企業の財務・戦略的SWOT分析
    Ascena Retail Group, Inc. (ASNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nachi-Fujikoshi Corp.
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Wageningen University-製薬・医療分野:企業M&A・提携分析
    Summary Wageningen University (WU), a subsidiary of Wageningen University and Research Centre, is an education and research institution. The university offers bachelors’, masters’ and PhD programs. It specializes in healthy food and living environment domain. WU offers various courses in bachelor of …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Engie S.A.:企業のM&A・事業提携・投資動向
    Engie S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Engie S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Bdo Unibank Inc
    Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Origin Energy Limited:企業の戦略・SWOT・財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Qualcomm Incorporated (QCOM)-エネルギー分野:企業M&A・提携分析
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …
  • Indigo Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. …
  • Connect Group PLC (CNCT):企業の財務・戦略的SWOT分析
    Connect Group PLC (CNCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gerdau S.A.:企業の戦略・SWOT・財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Neurim Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Neurim Pharmaceuticals Ltd (Neurim) is a drug discovery company that develops drugs for central nervous system diseases.The company's product line includes circadin that is used in insomnia treatment. Neurim offers paediatric prolonged-release melatonin, piromelatine, NEU-P12 and NEU-240. Th …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Ocular Therapeutix Inc (OCUL):製薬・医療:M&Aディール及び事業提携情報
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆